Tianjin Pharmaceutical Da Ren Tang Sets Jun, 10 2026 Online Briefing for FY2025 and Q1 2026 Results

SGX Filings

Jun 02

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited will host an online investor conference on Jun, 10 2026 from 3:00 p.m. to 4:00 p.m. to discuss its financial results for the year ended Dec, 31 2025 and the three-month period ended Mar, 31 2026.

The session will be held via the Eastmoney Roadshow platform, where shareholders can participate in real time.

Investors may submit questions in advance by emailing drt600329@163.com before 5:00 p.m. on Jun, 5 2026; selected questions of broad interest will be addressed during the briefing.

Chairman Wang Lei, Independent and Non-Executive Director Zhai Shuping, Chief Financial Officer Ma Jian and Board Secretary Jiao Yan will represent the company during the event.

A replay of the presentation will be available on the Eastmoney Roadshow website after the conference.

For further information, investors can contact Wang Jian or Jiang Ling at +86 22 2702 0892 or via the email address above.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1172492229"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1172492229\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1172492229?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-02 18:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172492229","market":"sg","top_or_hot":-1,"title":"Tianjin Pharmaceutical Da Ren Tang Sets Jun, 10 2026 Online Briefing for FY2025 and Q1 2026 Results","media":"SGX Filings","content":"\n<p>Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited will host an online investor conference on Jun, 10 2026 from 3:00 p.m. to 4:00 p.m. to discuss its financial results for the year ended Dec, 31 2025 and the three-month period ended Mar, 31 2026.</p>\n<p>The session will be held via the Eastmoney Roadshow platform, where shareholders can participate in real time.</p>\n<p>Investors may submit questions in advance by emailing drt600329@163.com before 5:00 p.m. on Jun, 5 2026; selected questions of broad interest will be addressed during the briefing.</p>\n<p>Chairman Wang Lei, Independent and Non-Executive Director Zhai Shuping, Chief Financial Officer Ma Jian and Board Secretary Jiao Yan will represent the company during the event.</p>\n<p>A replay of the presentation will be available on the Eastmoney Roadshow website after the conference.</p>\n<p>For further information, investors can contact Wang Jian or Jiang Ling at +86 22 2702 0892 or via the email address above.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tianjin Pharmaceutical Da Ren Tang Sets Jun, 10 2026 Online Briefing for FY2025 and Q1 2026 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTianjin Pharmaceutical Da Ren Tang Sets Jun, 10 2026 Online Briefing for FY2025 and Q1 2026 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2026-06-02 18:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n\n<p>Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited will host an online investor conference on Jun, 10 2026 from 3:00 p.m. to 4:00 p.m. to discuss its financial results for the year ended Dec, 31 2025 and the three-month period ended Mar, 31 2026.</p>\n<p>The session will be held via the Eastmoney Roadshow platform, where shareholders can participate in real time.</p>\n<p>Investors may submit questions in advance by emailing drt600329@163.com before 5:00 p.m. on Jun, 5 2026; selected questions of broad interest will be addressed during the briefing.</p>\n<p>Chairman Wang Lei, Independent and Non-Executive Director Zhai Shuping, Chief Financial Officer Ma Jian and Board Secretary Jiao Yan will represent the company during the event.</p>\n<p>A replay of the presentation will be available on the Eastmoney Roadshow website after the conference.</p>\n<p>For further information, investors can contact Wang Jian or Jiang Ling at +86 22 2702 0892 or via the email address above.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"T14.SI","symbol_name":"达仁堂","start_time":0,"source_url":"","article_id":"1172492229","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172492229","pubTimestamp":1780395042,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited will host an online investor conference on Jun, 10 2026 from 3:00 p.m. to 4:00 p.m. to discuss its financial results for the year ended...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"T14.SI":"达仁堂"},"translate_title":"天津药业达仁堂于2016年6月10日举行2025财年和2026年第一季度业绩在线简报会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"T14.SI":1},"content_text":"Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited will host an online investor conference on Jun, 10 2026 from 3:00 p.m. to 4:00 p.m. to discuss its financial results for the year ended Dec, 31 2025 and the three-month period ended Mar, 31 2026.\nThe session will be held via the Eastmoney Roadshow platform, where shareholders can participate in real time.\nInvestors may submit questions in advance by emailing drt600329@163.com before 5:00 p.m. on Jun, 5 2026; selected questions of broad interest will be addressed during the briefing.\nChairman Wang Lei, Independent and Non-Executive Director Zhai Shuping, Chief Financial Officer Ma Jian and Board Secretary Jiao Yan will represent the company during the event.\nA replay of the presentation will be available on the Eastmoney Roadshow website after the conference.\nFor further information, investors can contact Wang Jian or Jiang Ling at +86 22 2702 0892 or via the email address above.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}